Siemens Healthineers boosts Q1 profits despite flat sales
The healthcare business at Siemens (NYSE:SI), Healthineers, boosted its fiscal 1st-quarter profits by nearly 15% despite flat sales, as the German industrial conglomerate’s shares surged to a 17-year...
View ArticleMedtronic wins FDA clearance for CardioInsight 3D mapping tech
Medtronic (NYSE:MDT) said today that it won 510(k) clearance from the FDA for its CardioInsight Noninvasive 3D mapping system, which was designed to map irregular heart rhythms in the upper and lower...
View ArticleIntuitive Surgical dodges class-action lawsuit over da Vinci robot-assisted...
Intuitive Surgical (NSDQ:ISRG) dodged a class-action product liability lawsuit yesterday when a federal judge in Georgia dismissed the case with prejudice. Plaintiffs Gabriel Fernando Nassar Cure and...
View ArticleGlide raises $4m for phase I trial of solid-dose teriparatide
Glide Technologies said today that it raised £3.2 million, or $4.0 million USD, in a round of financing. A number of existing investors contributed to the round, according to the Oxford-based company....
View ArticleHologic, Grifols close $2B Procleix blood-screening biz sale
Hologic (NSDQ:HOLX) said today that it closed the sale of its stake in the Procleix blood-screening business it runs with Grifols (NSDQ:GRFS) for nearly $1.9 billion. Hologic, which makes the Procleix...
View ArticleRoche denies rumors it will shop diabetes unit, earnings
Roche (PINK:RHHBY) denied rumors that it was considering selling its diabetes unit today, saying that it is “committed” to the business. The company also predicted that competition and spending on new...
View ArticleBaxter beats on Q4 earnings, misses on revenue
Shares in Baxter (NYSE:BAX) held steady today after the medical device maker exceeded earnings expectations on Wall Street with its 4th quarter results, but barely missed revenue estimates. The...
View ArticleBiotronik receives FDA warning on Berlin plant; launches Ilivia CRT-Ds
UPDATED Feb. 1, 2017, with comment from Biotronik. The FDA this week released a warning letter it sent to Biotronik over issues it identified during an inspection of its facilities in Berlin, shortly...
View ArticleExactech deals spine biz to ChoiceSpine
Exactech (NSDQ:EXAC) said it sold off its spine business yesterday to ChoiceSpine for an undisclosed amount and plans to restructure its biologics business. “For nearly a decade, Exactech has driven...
View ArticleInvacare continues restructuring, lays off 100
Invacare (NYSE:IVC) said yesterday it cut 100 employees from its workforce as the company continues to restructure. The Elyria, Ohio-based company said it expects to incur restructuring charges of...
View ArticleGI Dynamics notches German reimbursement win
GI Dynamics (ASX:GID) said today that its EndoBarrier device won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System. This status is the highest of 4 levels, which...
View ArticleStudy finds higher complication risk with Cardinal Health’s Mynx vascular...
A study published last week in The New England Journal of Medicine concluded that patients treated with Cardinal Health (NYSE:CAH)’s Mynx vascular closure device are at higher risk for vascular...
View ArticleVascular Solutions shareholders sue to block $1B Teleflex buyout
A group of Vascular Solutions (NSDQ:VASC) shareholders last week sued to block a $1 billion buyout by Teleflex (NYSE:TFX), arguing that the deal undervalues Vascular Solutions and locks out any...
View ArticleCohero raises $13.3m for connected inhaler tech
Cohero Health said today that it raised more than $13.3 million, according to regulatory filings, in equity and Series A preferred stock. The company sold nearly all of its total offering amount of...
View ArticleMassDevice.com +5 | The top 5 medtech stories for February 1, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleCerulean reviews clinical assets, nanoparticle-drug conjugates
Cerulean Pharma Inc. (NSDQ:CERU) said today that its board of directors launched a strategic review of its assests, considering alternatives for its clinical assets and nanoparticle-drug conjugate...
View ArticleEntellus closes $40m offering
Entellus Medical (NSDQ:ENTL) said today that it closed a $37.2 million underwritten offering with existing stockholders. The company sold 2,353,530 shares of its common stock at $0.001 per share and...
View ArticleEdwards shares lift on Q4, FY2016 earnings beat
Shares in Edwards Lifesciences (NYSE:EW) rose today in after hours trading after the medical device beat expectations on Wall Street with its 4th quarter and full fiscal year 2016 results. The Irvine,...
View Article11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the...
View ArticleHologic shares droop despite Q1 beat
Shares in Hologic (NSDQ:HOLX) fell today in after hours trading despite the medical device maker beating expectations on Wall Street with its 1st quarter results. The Marlborough, Mass.-based company...
View Article
More Pages to Explore .....